Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Han Y, Zhang J, Yang Z, Jian W, Zhu Y, Gao S, Liu Y, Li Y, He S, Zhang C, Li Y, You B, Liu J, Du J. Palmdelphin Deficiency Evokes NF-κB Signaling in Valvular Endothelial Cells and Aggravates Aortic Valvular Remodeling. JACC Basic Transl Sci 2023;8:1457-1472. [PMID: 38093741 PMCID: PMC10714178 DOI: 10.1016/j.jacbts.2023.06.004] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/14/2023] [Revised: 06/12/2023] [Accepted: 06/12/2023] [Indexed: 01/24/2024]

For:	Han Y, Zhang J, Yang Z, Jian W, Zhu Y, Gao S, Liu Y, Li Y, He S, Zhang C, Li Y, You B, Liu J, Du J. Palmdelphin Deficiency Evokes NF-κB Signaling in Valvular Endothelial Cells and Aggravates Aortic Valvular Remodeling. JACC Basic Transl Sci 2023;8:1457-1472. [PMID: 38093741 PMCID: PMC10714178 DOI: 10.1016/j.jacbts.2023.06.004] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/14/2023] [Revised: 06/12/2023] [Accepted: 06/12/2023] [Indexed: 01/24/2024]

Number

Cited by Other Article(s)

Qian X, Xu L, Geng B, Li F, Dong N. Navigating the Landscape of Translational Medicine of Calcific Aortic Valve Disease: Bridging Bench to Bedside. JACC. ASIA 2025;5:503-515. [PMID: 40180541 DOI: 10.1016/j.jacasi.2025.01.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/13/2024] [Revised: 12/16/2024] [Accepted: 01/14/2025] [Indexed: 04/05/2025]

Blaser MC, Bäck M, Lüscher TF, Aikawa E. Calcific aortic stenosis: omics-based target discovery and therapy development. Eur Heart J 2025;46:620-634. [PMID: 39656785 PMCID: PMC11825147 DOI: 10.1093/eurheartj/ehae829] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/19/2024] [Revised: 10/01/2024] [Accepted: 11/14/2024] [Indexed: 12/17/2024] Open

Long Y, Huang F, Zhang J, Zhang J, Cheng R, Zhu L, Chen Q, Yang D, Pan X, Yang W, Qin M, Huang J. Identification of SUMOylation-related signature genes associated with immune infiltration in ulcerative colitis through bioinformatics analysis and experimental validation. Gene 2025;935:148996. [PMID: 39395728 DOI: 10.1016/j.gene.2024.148996] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2024] [Revised: 09/13/2024] [Accepted: 10/09/2024] [Indexed: 10/14/2024]

Abstract

OBJECTIVE

Ulcerative colitis (UC) is a chronic inflammatory disorder challenging to diagnose clinically. We focused on identifying and validating SUMOylation-related signature genes in UC and their association with immune infiltration.

METHODS

Five eligible gene expression profiles were selected from the Gene Expression Omnibus (GEO) database and merged into a single dataset comprising 260 UC patients and 76 healthy controls (HC). Differentially expressed genes (DEGs) were identified, and these were intersected with SUMOylation-related genes to obtain differentially expressed SUMOylation-related genes (DESRGs). Next, we identify the signature genes and validate them through comprehensive analyses employing GO, KEGG, GSVA, Lasso-cox regression, ROC curves, and clustering analysis. The infiltrating immune cells were analyzed using the CIBERSORT algorithm and Pearson correlation analysis. Finally, in vitro and in vivo experiments validated the identified signature genes.

RESULTS

PALMD, THRB, MAGED1, PARP1, and SLC16A1 were identified. Next, an excellent predictive model for UC was established and distinct subgroups of patients associated with SUMOylation were identified. Moreover, the NF-κB signaling pathway likely plays a pivotal role in the regulation of SUMOylation in UC. Additionally, we validated that the alterations in PALMD, THRB, and MAGED1 expression in LPS-induced Caco-2 cells concurred with our bioinformatics findings, particularly demonstrating statistically significant differences in PALMD and THRB expression. Finally, in a DSS-induced mouse colitis model, we observed a significant upregulation of PALMD expression. Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation.

CONCLUSION

This study comprehensively elucidates the biological roles of SUMOylation-related genes in UC, identifying PALMD, MAGED1, THRB, PARP1, and SLC16A1 as signature genes that represent promising biomarkers for UC diagnosis and prognosis.

Collapse

Affiliation(s)

Ying Long Department of Gastroenterology, the Second Affiliated Hospital of Guangxi Medical University, Nanning 530007, People's Republic of China; Department of Gastroenterology, Liuzhou People's Hospital Affiliated to Guangxi Medical University, Liuzhou 545006, People's Republic of China
Feihong Huang Spine and Osteopathy Ward, the First Affiliated Hospital of Guangxi Medical University, Nanning 530021, People's Republic of China
Juan Zhang Department of Pediatrics, Zhuzhou Central Hospital, Zhuzhou 412000, People's Republic of China
Jinxiu Zhang Department of Gastroenterology, the Second Affiliated Hospital of Guangxi Medical University, Nanning 530007, People's Republic of China
Ruoxi Cheng Department of Gastroenterology, the Second Affiliated Hospital of Guangxi Medical University, Nanning 530007, People's Republic of China
Liye Zhu Department of Gastroenterology, the Second Affiliated Hospital of Guangxi Medical University, Nanning 530007, People's Republic of China
Qiuling Chen Department of Gastroenterology, the Second Affiliated Hospital of Guangxi Medical University, Nanning 530007, People's Republic of China
Dan Yang Department of Gastroenterology, the Second Affiliated Hospital of Guangxi Medical University, Nanning 530007, People's Republic of China
Xiaoping Pan Department of Gastroenterology, the Second Affiliated Hospital of Guangxi Medical University, Nanning 530007, People's Republic of China
Wenfang Yang Department of Gastroenterology, the Second Affiliated Hospital of Guangxi Medical University, Nanning 530007, People's Republic of China
Mengbin Qin Department of Gastroenterology, the Second Affiliated Hospital of Guangxi Medical University, Nanning 530007, People's Republic of China.
Jiean Huang Department of Gastroenterology, the Second Affiliated Hospital of Guangxi Medical University, Nanning 530007, People's Republic of China.

Collapse

Qian C, Dong G, Yang C, Zheng W, Zhong C, Shen Q, Lu Y, Zhao Y. Broadening horizons: molecular mechanisms and disease implications of endothelial-to-mesenchymal transition. Cell Commun Signal 2025;23:16. [PMID: 39789529 PMCID: PMC11720945 DOI: 10.1186/s12964-025-02028-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2024] [Accepted: 01/03/2025] [Indexed: 01/12/2025] Open

Ma XR, Conley SD, Kosicki M, Bredikhin D, Cui R, Tran S, Sheth MU, Qiu WL, Chen S, Kundu S, Kang HY, Amgalan D, Munger CJ, Duan L, Dang K, Rubio OM, Kany S, Zamirpour S, DePaolo J, Padmanabhan A, Olgin J, Damrauer S, Andersson R, Gu M, Priest JR, Quertermous T, Qiu X, Rabinovitch M, Visel A, Pennacchio L, Kundaje A, Glass IA, Gifford CA, Pirruccello JP, Goodyer WR, Engreitz JM. Molecular convergence of risk variants for congenital heart defects leveraging a regulatory map of the human fetal heart. MEDRXIV : THE PREPRINT SERVER FOR HEALTH SCIENCES 2024:2024.11.20.24317557. [PMID: 39606363 PMCID: PMC11601760 DOI: 10.1101/2024.11.20.24317557] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 11/29/2024]

Abstract

Congenital heart defects (CHD) arise in part due to inherited genetic variants that alter genes and noncoding regulatory elements in the human genome. These variants are thought to act during fetal development to influence the formation of different heart structures. However, identifying the genes, pathways, and cell types that mediate these effects has been challenging due to the immense diversity of cell types involved in heart development as well as the superimposed complexities of interpreting noncoding sequences. As such, understanding the molecular functions of both noncoding and coding variants remains paramount to our fundamental understanding of cardiac development and CHD. Here, we created a gene regulation map of the healthy human fetal heart across developmental time, and applied it to interpret the functions of variants associated with CHD and quantitative cardiac traits. We collected single-cell multiomic data from 734,000 single cells sampled from 41 fetal hearts spanning post-conception weeks 6 to 22, enabling the construction of gene regulation maps in 90 cardiac cell types and states, including rare populations of cardiac conduction cells. Through an unbiased analysis of all 90 cell types, we find that both rare coding variants associated with CHD and common noncoding variants associated with valve traits converge to affect valvular interstitial cells (VICs). VICs are enriched for high expression of known CHD genes previously identified through mapping of rare coding variants. Eight CHD genes, as well as other genes in similar molecular pathways, are linked to common noncoding variants associated with other valve diseases or traits via enhancers in VICs. In addition, certain common noncoding variants impact enhancers with activities highly specific to particular subanatomic structures in the heart, illuminating how such variants can impact specific aspects of heart structure and function. Together, these results implicate new enhancers, genes, and cell types in the genetic etiology of CHD, identify molecular convergence of common noncoding and rare coding variants on VICs, and suggest a more expansive view of the cell types instrumental in genetic risk for CHD, beyond the working cardiomyocyte. This regulatory map of the human fetal heart will provide a foundational resource for understanding cardiac development, interpreting genetic variants associated with heart disease, and discovering targets for cell-type specific therapies.

Collapse

Affiliation(s)

X Rosa Ma Basic Science and Engineering (BASE) Initiative, Stanford Children's Health, Betty Irene Moore Children's Heart Center, Stanford, CA, USA Department of Genetics, Stanford University, Stanford, CA, USA
Stephanie D Conley Basic Science and Engineering (BASE) Initiative, Stanford Children's Health, Betty Irene Moore Children's Heart Center, Stanford, CA, USA Department of Genetics, Stanford University, Stanford, CA, USA
Michael Kosicki Environmental Genomics and Systems Biology Division, Lawrence Berkeley National Laboratory, Berkeley, CA, USA
Danila Bredikhin Basic Science and Engineering (BASE) Initiative, Stanford Children's Health, Betty Irene Moore Children's Heart Center, Stanford, CA, USA Department of Genetics, Stanford University, Stanford, CA, USA
Ran Cui Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA The Novo Nordisk Foundation Center for Genomic Mechanisms of Disease, Broad Institute of MIT and Harvard, Cambridge, MA, USA
Steven Tran Department of Pediatrics, Stanford University, Stanford, CA, USA
Maya U Sheth Basic Science and Engineering (BASE) Initiative, Stanford Children's Health, Betty Irene Moore Children's Heart Center, Stanford, CA, USA Department of Genetics, Stanford University, Stanford, CA, USA Department of Bioengineering, Stanford University, Stanford, CA, USA
Wei-Lin Qiu The Novo Nordisk Foundation Center for Genomic Mechanisms of Disease, Broad Institute of MIT and Harvard, Cambridge, MA, USA Department of Biology, University of Copenhagen, Copenhagen, Denmark
Sijie Chen Basic Science and Engineering (BASE) Initiative, Stanford Children's Health, Betty Irene Moore Children's Heart Center, Stanford, CA, USA Department of Genetics, Stanford University, Stanford, CA, USA Department of Computer Science, Stanford University, Stanford, CA, USA
Soumya Kundu Department of Genetics, Stanford University, Stanford, CA, USA Department of Computer Science, Stanford University, Stanford, CA, USA
Helen Y Kang Basic Science and Engineering (BASE) Initiative, Stanford Children's Health, Betty Irene Moore Children's Heart Center, Stanford, CA, USA Department of Genetics, Stanford University, Stanford, CA, USA Current address: PhD Program in Computational and Systems Biology, MIT, Cambridge, MA, USA
Dulguun Amgalan Basic Science and Engineering (BASE) Initiative, Stanford Children's Health, Betty Irene Moore Children's Heart Center, Stanford, CA, USA Department of Genetics, Stanford University, Stanford, CA, USA Maternal and Child Health Research Institute, Stanford University, Stanford, CA, USA
Chad J Munger Basic Science and Engineering (BASE) Initiative, Stanford Children's Health, Betty Irene Moore Children's Heart Center, Stanford, CA, USA Department of Genetics, Stanford University, Stanford, CA, USA
Lauren Duan Department of Pediatrics, Stanford University, Stanford, CA, USA
Katherine Dang Department of Pediatrics, Stanford University, Stanford, CA, USA
Oriane Matthys Rubio Basic Science and Engineering (BASE) Initiative, Stanford Children's Health, Betty Irene Moore Children's Heart Center, Stanford, CA, USA Department of Pediatrics, Stanford University, Stanford, CA, USA
Shinwan Kany Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, MA, USA Cardiovascular Research Center, Massachusetts General Hospital, Boston, MA, USA Department of Cardiology, University Heart and Vascular Center Hamburg-Eppendorf, Hamburg, Germany German Center for Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Lübeck, Hamburg, Germany
Siavash Zamirpour School of Medicine, University of California San Francisco, San Francisco, CA, USA
John DePaolo Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
Arun Padmanabhan Gladstone Institutes, San Francisco, CA, USA Department of Medicine, University of California San Francisco School of Medicine, San Francisco, CA, USA Chan Zuckerberg Biohub, San Francisco, CA, USA
Jeffrey Olgin Division of Cardiology, Department of Medicine and Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA, USA
Scott Damrauer Division of Vascular Surgery and Endovascular Therapy, Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA Corporal Michael Crescenz VA Medical Center, Philadelphia, PA, USA Penn Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
Robin Andersson The Novo Nordisk Foundation Center for Genomic Mechanisms of Disease, Broad Institute of MIT and Harvard, Cambridge, MA, USA Department of Biology, University of Copenhagen, Copenhagen, Denmark
Mingxia Gu Center for Stem Cell and Organoid Medicine, Division of Pulmonary Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA University of Cincinnati School of Medicine, Cincinnati, OH, USA
James R Priest Department of Pediatrics, Stanford University, Stanford, CA, USA Tenaya Therapeutics, South San Francisco, CA, USA
Thomas Quertermous Department of Genetics, Stanford University, Stanford, CA, USA Department of Medicine, Stanford University, Stanford, CA, USA Stanford Cardiovascular Institute, Stanford University, Stanford, CA, USA
Xiaojie Qiu Basic Science and Engineering (BASE) Initiative, Stanford Children's Health, Betty Irene Moore Children's Heart Center, Stanford, CA, USA Department of Genetics, Stanford University, Stanford, CA, USA Department of Computer Science, Stanford University, Stanford, CA, USA Maternal and Child Health Research Institute, Stanford University, Stanford, CA, USA Stanford Cardiovascular Institute, Stanford University, Stanford, CA, USA Stanford Bio-X, Stanford University, Stanford, CA, USA
Marlene Rabinovitch Basic Science and Engineering (BASE) Initiative, Stanford Children's Health, Betty Irene Moore Children's Heart Center, Stanford, CA, USA Department of Pediatrics, Stanford University, Stanford, CA, USA Stanford Cardiovascular Institute, Stanford University, Stanford, CA, USA Vera Moulton Wall Center for Pulmonary Vascular Diseases, Stanford University, Stanford, CA, USA
Axel Visel Environmental Genomics and Systems Biology Division, Lawrence Berkeley National Laboratory, Berkeley, CA, USA US Department of Energy Joint Genome Institute, Lawrence Berkeley National Laboratory, Berkeley, CA, USA School of Natural Sciences, University of California, Merced, Merced, CA, USA
Len Pennacchio Environmental Genomics and Systems Biology Division, Lawrence Berkeley National Laboratory, Berkeley, CA, USA US Department of Energy Joint Genome Institute, Lawrence Berkeley National Laboratory, Berkeley, CA, USA Comparative Biochemistry Program, University of California, Berkeley, CA, 94720, USA
Anshul Kundaje Department of Genetics, Stanford University, Stanford, CA, USA Department of Computer Science, Stanford University, Stanford, CA, USA
Ian A Glass Maternal and Child Health Research Institute, Stanford University, Stanford, CA, USA Department of Pediatrics and Medicine, University of Washington School of Medicine, Seattle, WA, USA
Casey A Gifford Basic Science and Engineering (BASE) Initiative, Stanford Children's Health, Betty Irene Moore Children's Heart Center, Stanford, CA, USA Department of Genetics, Stanford University, Stanford, CA, USA Department of Pediatrics, Stanford University, Stanford, CA, USA Maternal and Child Health Research Institute, Stanford University, Stanford, CA, USA Stanford Cardiovascular Institute, Stanford University, Stanford, CA, USA Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA, USA
James P Pirruccello Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, MA, USA Division of Cardiology, Department of Medicine and Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA, USA Institute for Human Genetics, University of California, San Francisco, CA, USA Bakar Computation Health Sciences Institute, University of California, San Francisco, CA, USA
William R Goodyer Department of Pediatrics, Stanford University, Stanford, CA, USA Maternal and Child Health Research Institute, Stanford University, Stanford, CA, USA Stanford Cardiovascular Institute, Stanford University, Stanford, CA, USA
Jesse M Engreitz Basic Science and Engineering (BASE) Initiative, Stanford Children's Health, Betty Irene Moore Children's Heart Center, Stanford, CA, USA Department of Genetics, Stanford University, Stanford, CA, USA The Novo Nordisk Foundation Center for Genomic Mechanisms of Disease, Broad Institute of MIT and Harvard, Cambridge, MA, USA Maternal and Child Health Research Institute, Stanford University, Stanford, CA, USA Stanford Cardiovascular Institute, Stanford University, Stanford, CA, USA Gene Regulation Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA

Collapse

Vassiliou VS, Johnson N, Langlands K, Tsampasian V. Genetics of Calcific Aortic Stenosis: A Systematic Review. Genes (Basel) 2024;15:1309. [PMID: 39457433 PMCID: PMC11508093 DOI: 10.3390/genes15101309] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2024] [Revised: 09/27/2024] [Accepted: 10/03/2024] [Indexed: 10/28/2024] Open

Abstract

Background: Calcific aortic stenosis is the most prevalent valvular abnormality in the Western world. Factors commonly associated with calcific aortic stenosis include advanced age, male sex, hypertension, diabetes and impaired renal function. This review synthesises the existing literature on genetic associations with calcific aortic stenosis. Methods: A systematic search was conducted in the PubMed, Ovid and Cochrane libraries from inception to 21 July 2024 to identify human studies investigating the genetic factors involved in calcific aortic stenosis. From an initial pool of 1392 articles, 78 were selected for full-text review and 31 were included in the final qualitative synthesis. The risk of bias in these studies was assessed using the Newcastle Ottawa Scale. Results: Multiple genes have been associated with calcific aortic stenosis. These genes are involved in different biological pathways, including the lipid metabolism pathway (PLA, LDL, APO, PCSK9, Lp-PLA2, PONS1), the inflammatory pathway (IL-6, IL-10), the calcification pathway (PALMD, TEX41) and the endocrine pathway (PTH, VIT D, RUNX2, CACNA1C, ALPL). Additional genes such as NOTCH1, NAV1 and FADS1/2 influence different pathways. Mechanistically, these genes may promote a pro-inflammatory and pro-calcific environment in the aortic valve itself, leading to increased osteoblastic activity and subsequent calcific degeneration of the valve. Conclusions: Numerous genetic associations contribute to calcific aortic stenosis. Recognition of these associations can enhance risk stratification for individuals and their first-degree relatives, facilitate family screening, and importantly, pave the way for targeted therapeutic interventions focusing on the identified genetic factors. Understanding these genetic factors can also lead to gene therapy to prevent calcific aortic stenosis in the future.

Collapse

Zhang J, Yang Z, Zhang C, Gao S, Liu Y, Li Y, He S, Yao J, Du J, You B, Han Y. PALMD haploinsufficiency aggravates extracellular matrix remodeling in vascular smooth muscle cells and promotes calcification. Am J Physiol Cell Physiol 2024;327:C1012-C1022. [PMID: 39246140 DOI: 10.1152/ajpcell.00217.2024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2024] [Revised: 08/20/2024] [Accepted: 08/23/2024] [Indexed: 09/10/2024]

Abstract

Reduced PALMD expression is strongly associated with the development of calcified aortic valve stenosis; however, the role of PALMD in vascular calcification remains unknown. Calcified arteries were collected from mice to detect PALMD expression. Heterozygous Palmd knockout (Palmd+/-) mice were established to explore the role of PALMD in subtotal nephrectomy-induced vascular calcification. RNA sequencing was applied to detect molecular changes in aortas from Palmd+/- mice. Primary Palmd+/- vascular smooth muscle cells (VSMCs) or PALMD-silenced VSMCs by short interfering RNA were used to analyze PALMD function in phenotypic changes and calcification. PALMD haploinsufficiency aggravated subtotal nephrectomy-induced vascular calcification. RNA sequencing analysis showed that loss of PALMD disturbed the synthesis and degradation of the extracellular matrix (ECM) in aortas, including collagens and matrix metalloproteinases (Col6a6, Mmp2, Mmp9, etc.). In vitro experiments revealed that PALMD-deficient VSMCs were more susceptible to high phosphate-induced calcification. Downregulation of SMAD6 expression and increased levels of p-SMAD2 were detected in Palmd+/- VSMCs, suggesting that transforming growth factor-β signaling may be involved in PALMD haploinsufficiency-induced vascular calcification. Our data revealed that PALMD haploinsufficiency causes ECM dysregulation in VSMCs and aggravates vascular calcification. Our findings suggest that reduced PALMD expression is also linked to vascular calcification, and PALMD may be a potential therapeutic target for this disease. NEW & NOTEWORTHY We found that PALMD haploinsufficiency causes extracellular matrix dysregulation, reduced PALMD expression links to vascular calcification, and PALMD mutations may lead to the risk of both calcific aortic valve stenosis and vascular calcification.

Collapse

Rasouli M, Safari F, Sobhani N, Alavi M, Roudi R. Regulation of Cellular-Signaling Pathways by Mammalian Proteins Containing Bacterial EPIYA or EPIYA-Like Motifs Predicted to be Phosphorylated. DNA Cell Biol 2024;43:74-84. [PMID: 38153368 DOI: 10.1089/dna.2023.0350] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2023] Open

Bäck M. Valvular Endothelium: A Genetically Susceptible Predilection Site for Calcific Aortic Valve Stenosis. JACC Basic Transl Sci 2023;8:1473-1474. [PMID: 38093749 PMCID: PMC10714160 DOI: 10.1016/j.jacbts.2023.09.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/16/2024]